切换至 "中华医学电子期刊资源库"

中华肥胖与代谢病电子杂志 ›› 2022, Vol. 08 ›› Issue (02) : 140 -145. doi: 10.3877/cma.j.issn.2095-9605.2022.02.012

会议纪要

2022年第三届中国国际"袖状胃+双通路手术"线上交流会会议概述
姚立彬1, 洪健1, 侯栋升1, 邵永1, 朱孝成1,()   
  1. 1. 221006 江苏徐州,徐州医科大学附属医院减重代谢外科
  • 收稿日期:2022-05-10 出版日期:2022-05-30
  • 通信作者: 朱孝成

Symposium summary of the third China International " sleeve gastrectomy with transit bipartition" online exchange conference in 2022

Libin Yao1, Jian Hong1, Dongsheng Yao1   

  • Received:2022-05-10 Published:2022-05-30
引用本文:

姚立彬, 洪健, 侯栋升, 邵永, 朱孝成. 2022年第三届中国国际"袖状胃+双通路手术"线上交流会会议概述[J]. 中华肥胖与代谢病电子杂志, 2022, 08(02): 140-145.

Libin Yao, Jian Hong, Dongsheng Yao. Symposium summary of the third China International " sleeve gastrectomy with transit bipartition" online exchange conference in 2022[J]. Chinese Journal of Obesity and Metabolic Diseases(Electronic Edition), 2022, 08(02): 140-145.

由徐州医科大学附属医院主办的第三届中国国际"袖状胃+双通路手术"线上交流会于2022年4月23日通过网络平台在线上顺利召开。徐州医科大学附属医院减重代谢外科中心主任朱孝成、巴西圣保罗阿尔伯特·安因斯坦医院Sergio Santorol共同担任本次大会执行主席。刘金钢、张忠涛、李威杰、王存川、朱晒红、宋军担任荣誉主席。田利国、王勇、梁辉、Philippe Topart、朱江帆、缪华担任共同主席。本次会议吸引了来自中国、巴西、埃及、法国、葡萄牙、智利及利比里亚共和国等7个国家,共计40余位国际、国内一流减重专家就"袖状胃+双通路"相关的热点话题进行了经验分享与学术讨论,全球共约2.5万余名学者线上参加此次网络会议,共享学术盛宴。现将本次会议内容整理如下:

[1]
Cho EY, Kemmet O, Frenken M. Biliopancreatic diversion with duodenal switch in patients with type 2 diabetes mellitus: is the chance of complete remission dependent on therapy and duration of insulin treatment [J]. Obes Facts, 2011, 4 Suppl 1: 18-23.
[2]
Santoro S, Castro LC, Velhote MC et al. Sleeve gastrectomy with transit bipartition: a potent intervention for metabolic syndrome and obesity [J]. Ann Surg, 2012, 256: 104-110.
[3]
Celik A, Ugale S. Functional restriction and a new balance between proximal and distal gut: the tools of the real metabolic surgery [J]. Obes Surg, 2014, 24: 1742-1743.
[4]
Santoro S, Velhote MC, Malzoni CE et al. Preliminary results from digestive adaptation: a new surgical proposal for treating obesity, based on physiology and evolution [J]. Sao Paulo Med J, 2006, 124: 192-197.
[5]
Azevedo FR, Santoro S, Correa-Giannella ML et al. A Prospective Randomized Controlled Trial of the Metabolic Effects of Sleeve Gastrectomy with Transit Bipartition [J]. Obes Surg, 2018, 28: 3012-3019.
[6]
Topart P, Becouarn G, Finel JB. Is transit bipartition a better alternative to biliopancreatic diversion with duodenal switch for superobesity? Comparison of the early results of both procedures [J]. Surg Obes Relat Dis 2020, 16: 497-502.
[7]
Bilecik T. Metabolic effects of sleeve gastrectomy with transit bipartition in obese females with type 2 diabetes mellitus: results after 1-year follow-up [J]. Obes Surg, 2019, 29: 805-810.
[8]
Arslan E, Sipahi M, Banli O. Early results of laparoscopic sleeve gastrectomy with loop bipartition [J]. Surg Laparosc Endosc Percutan Tech, 2018, 28: 385-389.
[9]
Mahdy T, Al Wahedi A, Schou C. Efficacy of single anastomosis sleeve ileal (sasi) bypass for type-2 diabetic morbid obese patients: gastric bipartition, a novel metabolic surgery procedure: a retrospective cohort study [J]. Int J Surg, 2016, 34: 28-34.
[10]
Cagiltay E, Celik A, Dixon JB et al. Effects of different metabolic states and surgical models on glucose metabolism and secretion of ileal L-cell peptides: results from the HIPER-1 study [J]. Diabet Med, 2020, 37: 697-704.
[11]
Al M, Taskin HE. Sleeve gastrectomy with transit bipartition in a series of 883 patients with mild obesity: early effectiveness and safety outcomes [J]. Surg Endosc, 2022, 36: 2631-2642.
[12]
Emile SH, Mahdy T. Excessive weight loss and hypoalbuminemia after sasi bypass: the need for standardization of the technique [J]. Obes Surg, 2021, 31: 865-866.
[13]
Topart P, Becouarn G, Finel JB. Comparison of 2-year results of Roux-en-Y gastric bypass and transit bipartition with sleeve gastrectomy for superobesity [J]. Obes Surg, 2020, 30: 3402-3407.
[14]
Chang P, Friedenberg F. Obesity and GERD [J]. Gastroenterol Clin North Am, 2014, 43: 161-173.
[15]
Peterli R, Wölnerhanssen BK, Peters T et al. Effect of Laparoscopic Sleeve Gastrectomy vs Laparoscopic Roux-en-Y Gastric Bypass on Weight Loss in Patients With Morbid Obesity: The SM-BOSS Randomized Clinical Trial [J]. Jama, 2018, 319: 255-265.
[16]
Musella M, Vitiello A, Berardi G et al. Evaluation of reflux following sleeve gastrectomy and one anastomosis gastric bypass: 1-year results from a randomized open-label controlled trial [J]. Surg Endosc, 2021, 35: 6777-6785.
[17]
Navarini D, Madalosso CAS, Tognon AP et al. Predictive Factors of Gastroesophageal Reflux Disease in Bariatric Surgery: a Controlled Trial Comparing Sleeve Gastrectomy with Gastric Bypass [J]. Obes Surg, 2020, 30: 1360-1367.
[18]
Balla A, Meoli F, Palmieri L et al. Manometric and pH-monitoring changes after laparoscopic sleeve gastrectomy: a systematic review [J]. Langenbecks Arch Surg, 2021, 406: 2591-2609.
[19]
Yeung KTD, Penney N, Ashrafian L et al. Does Sleeve Gastrectomy Expose the Distal Esophagus to Severe Reflux?: A Systematic Review and Meta-analysis [J]. Ann Surg, 2020, 271: 257-265.
[20]
Wang M, Widjaja J, Dolo PR et al. The Protective Effect of Transit Bipartition and Its Modification Against Sleeve Gastrectomy-Related Esophagitis in a Rodent Model [J]. Obes Surg, 2022, 32: 1149-1156.
[21]
Bruzzi M, Chevallier JM, Czernichow S. One-Anastomosis Gastric Bypass: Why Biliary Reflux Remains Controversial [J]? Obes Surg, 2017, 27: 545-547.
[22]
Widjaja J, Sun X, Chu Y et al. Sleeve Gastrectomy with Braun Anastomosis Transit Bipartition (B-TB): a Potential Midway Between Single Anastomosis and Roux-en-Y Transit Bipartition [J]. Obes Surg, 2021, 31: 5500-5503.
[23]
Sewefy AM, Saleh A. The outcomes of single anastomosis sleeve jejunal bypass as a treatment for morbid obesity (Two-year follow-up) [J]. Surg Endosc, 2021, 35: 5698-5704.
No related articles found!
阅读次数
全文


摘要